U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4602146021S-1 in Combination With Abraxane in Treating CholangiocarcinomaRecruitingNo Results AvailableCholangiocarcinomaDrug: S-1 plus Abraxanehttps://ClinicalTrials.gov/show/NCT01963325
4602246022Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.RecruitingNo Results AvailableTransurethral Resection of Prostate|Artery Embolization|Benign Prostatic Hyperplasia|Lower Urinary Tract SymptomsProcedure: Transarterial Supraselective Embolization of the prostate|Procedure: Transurethral Resection of the prostatehttps://ClinicalTrials.gov/show/NCT01963312
4602346023Clonidine - Ropivacaine in Peribulbar AnesthesiaCompletedNo Results AvailableIndication for Surgery of the Posterior Segment Under Locoregional AnaesthesiaDrug: 5 ml Ropivacaine 10% + physiological saline|Drug: 5 ml Ropivacaine 10% + Clonidine 1 µg/kghttps://ClinicalTrials.gov/show/NCT01963299
4602446024Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT DiscriminatorsActive, not recruitingNo Results AvailableTachycardiaDevice: ICD with enhanced SVT discriminatorshttps://ClinicalTrials.gov/show/NCT01963286
4602546025Video Assisted Ablation of Pilonidal SinusActive, not recruitingNo Results AvailablePilonidal SinusProcedure: Video Assisted Ablation of Pilonidal Sinushttps://ClinicalTrials.gov/show/NCT01963273
4602646026Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)CompletedNo Results AvailableImmune Thrombocytopenia PurpuraDrug: MK-8723|Drug: Matching Placebohttps://ClinicalTrials.gov/show/NCT01963260
4602746027An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNAâ„¢) Technology in the Management of Sport Related ConcussionCompletedNo Results AvailableHealthy|Minor Traumatic Brain Injury (TBI)https://ClinicalTrials.gov/show/NCT01963247
4602846028Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)RecruitingNo Results AvailableSubstance Use Disorders|HIVhttps://ClinicalTrials.gov/show/NCT01963234
4602946029Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly PatientsCompletedNo Results AvailableAging|InflammationRadiation: fludeoxyglucose(18f)|Other: blood sample|Other: cardiac and aortic magnetic resonance imaging|Other: carotid femoral pulse wave velocity|Radiation: positron emission tomography|Radiation: computed tomographyhttps://ClinicalTrials.gov/show/NCT01963221
4603046030Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label ExtensionRecruitingNo Results AvailableDrug Resistant Partial Onset SeizureDrug: ganaxolone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01963208
4603146031Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target TherapyNot yet recruitingNo Results AvailableNSCLCDrug: Icotinibhttps://ClinicalTrials.gov/show/NCT01963195
4603246032Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal CancerRecruitingNo Results AvailableFirst Line Metastatic Colorectal CancerDrug: Irinotecanhttps://ClinicalTrials.gov/show/NCT01963182
4603346033Dissemination of a Theory-Based Bone Health Program in OnlineActive, not recruitingNo Results AvailableOsteoporosis|Health BehaviorsBehavioral: TO-BoneHealth Program (Bone Power Program)|Behavioral: TO-BoneHealth Plus Program (Bone Power Plus Program)https://ClinicalTrials.gov/show/NCT01963169
4603446034Synchronization to Improve Non-Adherence to Cardiovascular MedicationsActive, not recruitingNo Results AvailableChronic Disease|Cardiovascular Disease|Diabetes MellitusBehavioral: Prescription synchronizationhttps://ClinicalTrials.gov/show/NCT01963156
4603546035Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency DiseasesRecruitingNo Results AvailablePrimary Immune Deficiency Disorders|Common Variable Immunodeficiency|X-linked Agammaglobulinaemia|Hyper-IgM SyndromeBiological: Gammaplex (5%)|Biological: Gammaplex 10https://ClinicalTrials.gov/show/NCT01963143
4603646036Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional StudyCompletedNo Results AvailableDrug Mechanism|Drug Usagehttps://ClinicalTrials.gov/show/NCT01963130
4603746037Effectiveness of the Combined Whole Liver Irradiation (WLI) and Hyperthermia for Gastrointestinal Tract Cancer Liver MetastasisTerminatedNo Results AvailableThe Patients With Unresectable Chemoresistant Multiple Liver Metastasis From Colorectal CancerRadiation: Combined hyperthermia and radiation therapyhttps://ClinicalTrials.gov/show/NCT01963117
4603846038Community-Based Kiosks for Hearing Screening and EducationEnrolling by invitationNo Results AvailableHearing LossProcedure: Automated hearing test|Procedure: Pure-tone Screener test|Procedure: Digits-in-noise test|Procedure: No screening test|Procedure: Automated hearing test/Motivation video|Procedure: Pure-tone Screener/Motivation video|Procedure: Digits-in-noise test/Motivational video|Procedure: No screening test/Motivational videohttps://ClinicalTrials.gov/show/NCT01963104
4603946039Effect of Oxytocin on Stress Response in Cocaine-dependent IndividualsCompletedHas ResultsCocaine DependenceDrug: oxytocin|Drug: salinehttps://ClinicalTrials.gov/show/NCT01963091
4604046040Sex/Gender Differences in Risk and Resilience to PTSD; Implication of OxytocinRecruitingNo Results AvailablePTSDDrug: Oxytocin|Drug: Salinehttps://ClinicalTrials.gov/show/NCT01963078
4604146041NICU-HEALTH (Hospital Exposures and Long-Term Health)RecruitingNo Results AvailablePreterm Birthhttps://ClinicalTrials.gov/show/NCT01963065
4604246042ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial CancerRecruitingNo Results AvailableMetastatic Urothelial CancerDrug: AGS15Ehttps://ClinicalTrials.gov/show/NCT01963052
4604346043A Trial of Vertebroplasty for Painful Chronic Osteoporotic Vertebral Fractures (Vertos V)RecruitingNo Results AvailableOsteoporosis|Vertebral FractureDevice: percutaneous vertebroplasty|Procedure: Sham procedurehttps://ClinicalTrials.gov/show/NCT01963039
4604446044Linking Brain to Behaviour Research in SCIRecruitingNo Results AvailableCervical Spinal Cord InjuryOther: ToCUEST featuring a 'variable practice' approach.|Other: ToCUEST featuring a 'constant practice' approach.https://ClinicalTrials.gov/show/NCT01963026
4604546045Non-returning Catheter Valve for Reducing CAUTICompletedNo Results AvailableCatheter Associated Urinary Tract Infection|Critically Ill PatientsDevice: Non-returning catheter valve|Device: Conventional urine baghttps://ClinicalTrials.gov/show/NCT01963013
4604646046Standardized Emergency Care for Community Acquired Pneumonia (CAP)CompletedNo Results AvailableCommunity Acquired Pneumonia|Pneumonia|Infectionhttps://ClinicalTrials.gov/show/NCT01963000
4604746047A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic KeratosisCompletedNo Results AvailableActinic KeratosisDrug: Diclofenac sodium|Other: Placebohttps://ClinicalTrials.gov/show/NCT01962987
4604846048A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)CompletedNo Results AvailableArthritis, RheumatoidBiological: Golimumab 2 mg/kg IVhttps://ClinicalTrials.gov/show/NCT01962974
4604946049N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older AdultsActive, not recruitingNo Results AvailableHIV|Endothelial Dysfunction|Oxidative StressDietary Supplement: PharmaNAC (N-acetylcysteine)|Dietary Supplement: Matching placebohttps://ClinicalTrials.gov/show/NCT01962961
4605046050Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerRecruitingNo Results AvailableRecurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity CancerDrug: paclitaxel|Drug: ganetespib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01962948

* Görseller ve İçerik tekif hakkına sahip olabilir